Jefferson University Hospitals

Provider Profile

Veda N. Giri, MD

Veda N. Giri, MD

Jefferson University Physician

Academic Title: Associate Professor
Director, Jefferson Clinical Cancer Genetics Service

Medical Oncology

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Bodine Center, 111 S. 11th Street
Philadelphia PA 19107
Phone: (215) 955-8516

Medical Services

Years in Practice


Board Certifications

  • Medical Oncology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital


  • Jefferson Medical College, Medical School


  • University of Michigan Hospital


  • University of Michigan Hospital


  • University of Michigan Hospital

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • Consumer Health Network PPO
  • CorVel
  • Employers Health Network PPO
  • Geisinger Health Plan
  • Health Management Network PPO
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Keystone First VIP Choice
  • Mercy LIFE
  • PlanCare America
  • Prime Health Services, Inc.
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017

Exploring Asian Indian and Pakistani views about cancer and participation in cancer genetics research: toward the development of a community genetics intervention

The role of genetic counseling in familial and sporadic cancer: Considerations, challenges, and collaboration

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts

Familial prostate cancer

HOXB13 and other high penetrant genes for prostate cancer

High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort

Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project

How I Do It: Genetic counseling and genetic testing for inherited prostate cancer

Interest in genomic SNP testing for prostate cancer risk: A pilot survey

Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer

Gene panel testing for inherited cancer risk

Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer

Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer

Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study

Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men

Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program

Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection